article thumbnail

CHMP meeting highlights – May 2025

European Pharmaceutical Review

Generic medicine Emtricitabine/Tenofovir alafenamide Viatris (emtricitabine / tenofovir alafenamide), received a positive opinion to treat adults and adolescents with human immunodeficiency virus type 1 (HIV-1). The Irish medicines regulatory agency, requested this action under Article 31 of Directive 2001/83/EC.

article thumbnail

Pathbreakers: The journey of first generics

Pharmaceutical Technology

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. However, that percentage of multiple first generics is not very high—approximately 10.6% from 2001 to 2022.”

FDA